Ligand conjugated low-density lipoprotein nanoparticles for enhanced optical cancer imaging in vivo

Juan Chen, Ian R. Corbin, Hui Li, Weiguo Cao, Jerry D. Glickson, Gang Zheng

Research output: Contribution to journalArticle

90 Scopus citations


LDL particles are high-capacity nanocarriers with precisely controlled size and are naturally biocompatible, biodegradable, and nonimmunogenic. However, their utilities as drug carriers are limited by the narrow purview of LDL receptor-positive tumors. Here, we synthsized a ligand-conjugated, NIR-labeled LDL that enables the first in vivo demonstration of rerouting LDL from LDL receptors to selected alternate receptors, thus drastically expanding the range of using LDL particles as nanocarriers for in vivo cancer imaging and treatment.

Original languageEnglish (US)
Pages (from-to)5798-5799
Number of pages2
JournalJournal of the American Chemical Society
Issue number18
StatePublished - May 9 2007


ASJC Scopus subject areas

  • Catalysis
  • Chemistry(all)
  • Biochemistry
  • Colloid and Surface Chemistry

Cite this